Vanderbilt-Ingram Cancer Center

It’s been two years since Joan Meredith’s stem cell transplant for acute myeloid leukemia (AML). Although she is now “100 percent donor” and her new immune system appears to be functioning well, she remains vigilant against the health complications related to her transplant – like infections, for example. “I hated wearing the mask because I [...]

Cancer patients who are undergoing treatment with chemotherapy or radiation therapy expect to experience side effects like nausea, fatigue and possible hair loss. But they may not realize that those treatments can cause additional side effects like dry skin, rashes and complexion changes. To help patients cope with these hair and skin issues, Vanderbilt-Ingram Cancer [...]

Are you currently going through lung cancer or pancreatic cancer treatment or have completed therapy? Jay Groves, administrative director at Vanderbilt Dayani Center, describes the new Vanderbilt Cancer Wellness Program. This program promotes the health and wellbeing of those touched by cancer through interactive, individualized and comprehensive services that complement your standard of care. Learn [...]

Most patients diagnosed with adult T-cell leukemia/lymphoma (ATLL) – a rare, aggressive blood cancer – will die within a year of diagnosis. No currently available treatments alter the disease’s aggressive clinical course. Utpal Davé, M.D., and colleagues are working to identify genes and pathways that drive or initiate ATLL. In the Oct. 6 issue of [...]

Barbara Forbes, MSN, keeps a big jar of tar on her desk. The dark, goopy mess is a visual representation of the amount of tar that a smoker will ingest by smoking one pack of cigarettes per day for a year. Forbes is the director of the Smoking Cessation Institute at the Vanderbilt Dayani Center [...]

Vanderbilt University has issued an open invitation to the Middle Tennessee community to join the VU team for the 2011 Light the Night cancer walk which will be held Friday, Oct. 14. Light the Night is the major fundraising event for the Leukemia and Lymphoma Society (LLS), the world’s largest organization dedicated to funding research [...]

The functions of most members of the enzyme family known as poly (ADP-ribose) polymerases (PARPs) are unclear. Some PARP-related proteins are in a B aggressive lymphoma (BAL) protein family, which are highly expressed in certain types of B cell lymphomas – malignancies of the antibody-producing B lymphocytes. Sung Hoon Cho, Ph.D., Mark Boothby, M.D., Ph.D., [...]

While September is a special month as it marks the 10-year anniversary of the 9/11 terrorist attacks, it is also a time to raise awareness about leukemia, lymphoma, childhood cancers, prostate cancer, ovarian cancer, thyroid cancer and liver cancer. Leukemia and lymphoma affect children and adults. Leukemia is a type of cancer of the blood [...]

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center, has received a grant from the Samuel Waxman Cancer Research Foundation (SWCRF) to study genetic mutations related to B-cell lymphoma. The grant will help launch Hiebert’s research into the cascade of mutations that lead to B-cell lymphoma. The Max Cure Foundation has agreed [...]

Vanderbilt-Ingram Cancer Center (VICC) is gearing up for Light the Night, a fund-raising event for the Leukemia & Lymphoma Society, Thursday, Oct. 7, at LP Field. Vanderbilt University will field a team for the visually exciting event which supports the Leukemia and Lymphoma Society’s activities to fund medical research, support government advocacy and patient assistance [...]